Mitotherapeutix LLC SBIR Phase I Award, June 2021
A SBIR Phase I contract was awarded to Mitotherapeutix LLC in June, 2021 for $253,050.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Name
# Contributions
Last Contribution
Find more entities like Mitotherapeutix LLC SBIR Phase I Award, June 2021
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.